$290,000 of CHEVRON PHILLIPS CHEMICAL COMPANY LP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
“H.R. 6566 – Recycling Technology Innovation Act; H.R. 7502 -Recycled Materials Attribution Act”
You can find more data on corporate lobbying on Quiver Quantitative.
CVX Congressional Stock Trading
Members of Congress have traded $CVX stock 15 times in the past 6 months. Of those trades, 5 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CVX stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/12, 03/11, 02/26.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 6 times. They made 3 purchases worth up to $80,000 on 02/10, 11/18, 10/17 and 3 sales worth up to $80,000 on 01/09, 12/24.
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.
- REPRESENTATIVE ROGER WILLIAMS sold up to $50,000 on 12/22.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 10/17.
To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard.
CVX Insider Trading Activity
CVX insiders have traded $CVX stock on the open market 54 times in the past 6 months. Of those trades, 0 have been purchases and 54 have been sales.
Here’s a breakdown of recent trading of $CVX stock by insiders over the last 6 months:
- MICHAEL K WIRTH (Chairman and CEO) has made 0 purchases and 10 sales selling 593,324 shares for an estimated $103,894,465.
- JOHN B HESS has made 0 purchases and 6 sales selling 550,000 shares for an estimated $82,749,549.
- R. HEWITT PATE (Chief Legal Officer) has made 0 purchases and 10 sales selling 222,009 shares for an estimated $42,441,376.
- MARK A NELSON (Vice Chairman) has made 0 purchases and 4 sales selling 185,400 shares for an estimated $34,210,618.
- EIMEAR P BONNER (Chief Financial Officer) has made 0 purchases and 8 sales selling 113,768 shares for an estimated $20,175,552.
- ANDREW BENJAMIN WALZ (President, DM&C) has made 0 purchases and 5 sales selling 35,929 shares for an estimated $6,497,661.
- THOMAS RYDER BOOTH (Chief Technology & Eng Ofr) has made 0 purchases and 5 sales selling 18,203 shares for an estimated $3,318,479.
- ALANA K KNOWLES (Controller) has made 0 purchases and 4 sales selling 16,764 shares for an estimated $2,836,064.
- JEFF B GUSTAVSON (President, New Energies) has made 0 purchases and 2 sales selling 15,992 shares for an estimated $2,641,607.
To track insider transactions, check out Quiver Quantitative’s insider trading dashboard.
CVX Hedge Fund Activity
We have seen 1,692 institutional investors add shares of CVX stock to their portfolio, and 1,808 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 27,628,637 shares (-80.2%) from their portfolio in Q4 2025, for an estimated $4,210,880,565
- BERKSHIRE HATHAWAY INC added 8,091,570 shares (+6.6%) to their portfolio in Q4 2025, for an estimated $1,233,236,183
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 5,537,580 shares (+822.0%) to their portfolio in Q4 2025, for an estimated $843,982,567
- NORGES BANK added 5,451,569 shares (+28.7%) to their portfolio in Q4 2025, for an estimated $830,873,631
- PRIMECAP MANAGEMENT CO/CA/ removed 4,037,474 shares (-63.5%) from their portfolio in Q4 2025, for an estimated $615,351,412
- BANK OF NEW YORK MELLON CORP removed 3,107,278 shares (-15.8%) from their portfolio in Q4 2025, for an estimated $473,580,239
- PACER ADVISORS, INC. removed 2,976,806 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $453,695,002
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.
CVX Analyst Ratings
Wall Street analysts have issued reports on $CVX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a “Overweight” rating on 02/02/2026
- Freedom Capital Markets issued a “Sell” rating on 01/06/2026
- Citigroup issued a “Buy” rating on 01/05/2026
- Mizuho issued a “Outperform” rating on 12/12/2025
- HSBC issued a “Buy” rating on 12/01/2025
- Morgan Stanley issued a “Overweight” rating on 11/13/2025
- Piper Sandler issued a “Overweight” rating on 11/13/2025
To track analyst ratings and price targets for CVX, check out Quiver Quantitative’s $CVX forecast page.
CVX Price Targets
Multiple analysts have issued price targets for $CVX recently. We have seen 13 analysts offer price targets for $CVX in the last 6 months, with a median target of $206.0.
Here are some recent targets:
- Biraj Borkhataria from RBC Capital set a target price of $220.0 on 04/13/2026
- Sam Margolin from Wells Fargo set a target price of $222.0 on 04/09/2026
- Alastair Syme from Citigroup set a target price of $235.0 on 04/02/2026
- Devin McDermott from Morgan Stanley set a target price of $212.0 on 03/27/2026
- Nitin Kumar from Mizuho set a target price of $217.0 on 03/17/2026
- Betty Jiang from Barclays set a target price of $180.0 on 03/16/2026
- Ryan Todd from Piper Sandler set a target price of $242.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.